Cholesterol-lowering drugs inhibit lectin-like oxidized low-density lipoprotein-1 receptor function by membrane raft disruption

Molecular Pharmacology
Sara MatarazzoSilvia Biocca

Abstract

Lectin-like oxidized low-density lipoprotein (LOX-1), the primary receptor for oxidized low-density lipoprotein (ox-LDL) in endothelial cells, is up-regulated in atherosclerotic lesions. Statins are the principal therapeutic agents for cardiovascular diseases and are known to down-regulate LOX-1 expression. Whether the effect on the LOX-1 receptor is related to statin-mediated cholesterol-lowering activity is unknown. We investigate the requirement of cholesterol for LOX-1-mediated lipid particle internalization, trafficking, and processing and the role of statins as inhibitors of LOX-1 function. Disruption of cholesterol-rich membrane microdomains by acute exposure of cells to methyl-β-cyclodextrin or chronic exposure to different statins (lovastatin and atorvastatin) led to a spatial disorganization of LOX-1 in plasma membranes and a marked loss of specific LOX-1 function in terms of ox-LDL binding and internalization. Subcellular fractionation and immunochemical studies indicate that LOX-1 is naturally present in caveolae-enriched lipid rafts and, by cholesterol reduction, the amount of LOX-1 in this fraction is highly decreased (≥60%). In contrast, isoprenylation inhibition had no effect on the distribution and function of ...Continue Reading

References

Apr 15, 2000·Methods : a Companion to Methods in Enzymology·G R BousfieldV Y Butnev
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Dayuan LiJawahar L Mehta
Jan 8, 2004·The Journal of Cell Biology·Alessandra CambiCarl G Figdor
Jan 22, 2004·Circulation·Gabriele A M PlenzHorst Robenek
Mar 17, 2004·Atherosclerosis·Dianne Z HillyardAngus J M Cameron
Oct 30, 2004·The Journal of Biological Chemistry·Alessio CardinaleSilvia Biocca
Feb 8, 2005·The Journal of Biological Chemistry·HaJeung ParkJeffrey C Boyington
Jul 26, 2005·Trends in Cardiovascular Medicine·Xiang-An LiEric J Smart
Feb 14, 2006·Trends in Cardiovascular Medicine·Ravinder S VohraShervanthi Homer-Vanniasinkam
Feb 24, 2007·Nature Reviews. Molecular Cell Biology·Robert G Parton, Kai Simons
Mar 24, 2007·Current Treatment Options in Cardiovascular Medicine·Kausik K Ray, Christopher P Cannon
Dec 11, 2007·Trends in Molecular Medicine·Chao-Yung WangJames K Liao
Jan 15, 2008·Journal of Molecular and Cellular Cardiology·Silvia BioccaGiuseppe Novelli
May 30, 2008·American Journal of Physiology. Cell Physiology·Philippe G FrankMichael P Lisanti
Jan 6, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Philippe Dje N'GuessanStefan Hippenstiel
Feb 3, 2009·Virology·Gemma C CarterWilliam James
Apr 23, 2009·Virus Research·Abdul A Waheed, Eric O Freed
Aug 12, 2009·The FEBS Journal·Wei CaoHeather H Shih
Jun 29, 2010·The American Journal of Pathology·Carlos Fernández-HernandoWilliam C Sessa
Jul 7, 2010·Expert Review of Cardiovascular Therapy·Charitha L GoonasekaraDavid Fedida
Jul 13, 2011·The American Journal of the Medical Sciences·Sona MitraJawahar L Mehta
Oct 26, 2011·Biochimica Et Biophysica Acta·Peter W WinterB George Barisas

❮ Previous
Next ❯

Citations

Sep 17, 2013·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Jiang Qiong TangXu Ping Qin
Nov 21, 2013·International Journal of Molecular Sciences·Isabelle CorreFrançois Paris
Jun 17, 2014·Journal of Diabetes and Metabolic Disorders·Md Ashraful Alam, Md Mahbubur Rahman
Jun 15, 2014·Neuroscience Letters·Jialing Liu
Feb 26, 2013·The Journal of Pharmacology and Experimental Therapeutics·Yu-Miao WeiPin-Lan Li
Nov 6, 2012·Cellular and Molecular Life Sciences : CMLS·Suowen XuPeiqing Liu
May 8, 2015·Cell Cycle·Silvia BioccaMattia Falconi
Aug 13, 2013·Mediators of Inflammation·Angela PirilloAlberico Luigi Catapano
Jul 31, 2013·Biochemical and Biophysical Research Communications·Mattia FalconiSilvia Biocca
Apr 16, 2013·Biochemical and Biophysical Research Communications·Miyuki Kumano-KuramochiSachiko Machida
Oct 12, 2013·Archives of Biochemistry and Biophysics·Silvia BioccaMattia Falconi
Jun 1, 2016·Archives of Biochemistry and Biophysics·Kenya TerabeToshihisa Kojima
Jan 19, 2016·Cellular Microbiology·Tim FechtnerJohannes H Hegemann
Oct 27, 2015·PloS One·Magda GioiaSilvia Biocca
Apr 15, 2017·Genetic Testing and Molecular Biomarkers·Valentina BrunoFrancesca Amati
Jul 30, 2014·Journal of Leukocyte Biology·Shanthi Vadali, Steven R Post
May 9, 2018·Current Medicinal Chemistry·Ajoe John KattoorJawahar L Mehta
Jun 24, 2017·Current Infectious Disease Reports·Mohammed A BataisAref A Bin Abdulhak
May 5, 2018·PLoS Neglected Tropical Diseases·Edileuza Danieli da SilvaArnaldo Zaha
Feb 6, 2019·Cell Death & Disease·Sabina PucciGiuseppe Novelli
Apr 14, 2016·Biochemical Society Transactions·Andrew M Ellisdon, Michelle L Halls
Sep 29, 2020·British Journal of Pharmacology·Francesca LuchettiLuigi Iuliano
Jan 7, 2021·Cancer Gene Therapy·M MurdoccaF Sangiuolo
Apr 2, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jonas GronerMiriam Breunig
Jun 22, 2021·Biochimie·Stéphane OrlowskiEric Bruckert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.